Study On Venous Infusion Industry In China

Infusion solution, which is a large amount of medication delivered in a drip way directly into body with a certain speed, is a common clinical dosage form developed on the basis of practices and experiences. It features large clinical dose and stability. Due to its special clinical medicine, the quality requirement of infusion solution is much higher than ordinary injection and even has its unique requirements. In modern medical treatment, infusion solution, as a necessary common dosage form, is becoming more and more widespread.The big transfusion industry in China, from the annual output of a few hundreds of millions bottles (bags) in the mid1980s to the current world first in production and sales, has developed at an accelerating rate. Besides the obvious fast growth, the technology content and added value are also accelerating. After related department explicitly promulgated the regulation that big transfusion company must obtain the GMP certificate few years ago, the industry has been driven to a standard development track. In recent years, the development of big transfusion industry in our country has featured by fast-growing production capacity and capability, rich products specifications, various packaging materials and diversified marketing channels.Production and management of big transfusion, as a special product, is influenced by unique factors like politics, economy, culture and technology of our country. The basic stimulant of big transfusion industry lies in the social realities like large and aging population and stable growth of the living standard. And it gains financial support from shareholding system reform as well as merger and acquisition of the companies. In addition, the industry, taking the advantage of technological innovation, has promoted its product quality, transportation ways and application methods efficiently through upgrading production equipments and package. However, it is obvious that the imperfect systems of bidding and price management, which fail to regulate the medical market, should be enhanced to guide the industry.Foreign big transfusion industry emerges earlier than that of China; as a result, they have enhanced their quality control system, package, production equipments and product variety to meet the need of clinical treatment. By comparison, the industry in China has suffered from low industry concentration, product homogeneity, market disorder, severe competition in low level, and frequent accidents due to poor quality.To flourish the big transfusion industry in China, we should base on its features, grasp the market trend and right development direction, gradually solve the problems within it, and adopt various methods like enlarging production scale, enriching production variety, enhancing the product quality, integrating industry resources, developing intensive management to ensure a sustainable and healthy development of the industry.